News Sentiment

NMRA sentiment intelligence

Neumora Therapeutics, Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 47 Balanced news tone 34 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.68 Week of 10 Jul 2026
Weighted tone 47/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 26

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

+0.6% over one week, -5.6% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Neumora Therapeutics (NASDAQ:NMRA) Price Target Cut to $5.00 by Analysts at Royal Bank Of Canada

Market Reaction

Balanced read

53/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction 0.6% Price digesting
Trend fit Trend inactive -5.6% over four weeks
Fair value -75.2% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 20
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 26
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 13
simplywall.st 3
MT Newswires 2
Stocktwits 2
Stock Titan 2
TradingView 2
MarketBeat 1
timothysykes.com 1

Event Lens

What the news is about

Classified themes
Market update 21
Earnings 8
Analyst action 3
Regulatory and legal 2

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 34